Autoimmune encephalopathies

Neurologist

Volumn 13, Issue 3, 2007, Pages 140-147

  Vernino, Steven ^a   Geschwind, Michael ^b   Boeve, Bradley ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Cancer; Dementia; Methylprednisolone; Prednisone

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

APHASIA; AUTOIMMUNE DISEASE; AUTONOMIC HYPERREFLEXIA; BEHAVIOR DISORDER; BRAIN DISEASE; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; ELECTROENCEPHALOGRAPHY; HALLUCINATION; HASHIMOTO ENCEPHALOPATHY; HUMAN; INSOMNIA; MEMORY DISORDER; MENTAL DISEASE; MORVAN SYNDROME; MYOKYMIA; NONPARANEOPLASTIC AUTOIMMUNE LIMBIC ENCEPHALITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC LIMBIC ENCEPHALITIS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SERODIAGNOSIS; SYMPTOMATOLOGY; TEMPORAL LOBE EPILEPSY; TREMOR;

AGE OF ONSET; AUTOIMMUNE DISEASES; BRAIN; ENCEPHALITIS; HUMANS;

EID: 34248394293     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000259483.70041.55     Document Type: Review

References (48)

1. Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003; 78:1363-1368.
2. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123: 1481-1494.
3. Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol. 2004;56:702-708.
4. Saiz A, Graus F, Dalmau J, Pifarre A, Marin C, Tolosa E. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol. 1999;46:774-777.
5. Hernandez Echebarria LE, Saiz A, Graus F, et al. Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy. Neurology. 2000;54:1539-1540.
6. Corsellis JA, Goldberg GJ, Norton AR. "Limbic encephalitis" and its association with carcinoma. Brain. 1968;91:481-496.
7. Scheid R, Lincke T, Voltz R, von Cramon DY, Sabri O. Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol. 2004;61:1785-1789.
8. Fakhoury T, Abou-Khalil B, Kessler RM. Limbic encephalitis and hyperactive foci on PET scan. Seizure. 1999;8:427-431.
9. Brierly J, Corsellis J. Subacute encephalitis of later adult life mainly affecting the limbic areas. Brain. 1960;83:356-368.
10. Voltz R, Gultekin SH, Rosenfeld MR, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med. 1999;340:1788-1795.
11. Ahern GL, O'Connor M, Dalmau J, et al. Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia. Neurology. 1994;44:1270-1274.
12. Vernino S, Lennon VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res. 2004;10:7270-7275.
13. Cunningham JD, Burt ME. Limbic encephalitis secondary to malignant thymoma. Ann Thorac Surg. 1994;58:250-251.
14. McArdle JP, Millingen KS. Limbic encephalitis associated with malignant thymoma. Pathology (Phila). 1988;20:292-295.
15. Rees JH, Hain SF, Johnson MR, et al. The role of -[18F]fluoro-2- deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain. 2001;124:2223-2231.
16. Younes-Mhenni S, Janier MF, Cinotti L, et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain. 2004;127:2331-2338.
17. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004;56:715-719.
18. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998;50:652-657.
19. Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127:1831-1844.
20. Ances BM, Vitaliani R, Taylor RA, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764-1777.
21. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann neurol. 2007 Jan;61(1):25-36.
22. Vernino S, O'Neill BP, Marks RS, O'Fallon JR, Kimmel DW. Immunomodulatory Treatment Trial for Paraneoplastic Neurological Disorders. Neuro-Oncology. 2004;6:55-62.
23. Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed potassium channels are implicated in neuromyotonia. Ann Neurol. 1997;41:238-246.
24. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50:73-78.
25. Schott JM, Harkness K, Barnes J, della Rocchetta AI, Vincent A, Rossor MN. Amnesia, cerebral atrophy, and autoimmunity. [-erratum appears in Lancet. 2004 Jan 3;363(9402):86]. Lancet. 2003;361:1266.
26. Pozo-Rosich P, Clover L, Saiz A, Vincent A, Graus F. Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol. 2003; 54:530-533.
27. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004;62:1177-1182.
28. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibodyassociated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127:701-712.
29. McKnight K, Jiang Y, Hart Y, et al. Serum Antibodies in Epilepsy and Seizure-Associated Disorders. Neurology. 2005;65:1730-1736.
30. Vincent A, Lang B, Kleopa KA. Autoimmune channelopathies and related neurological disorders. Neuron. 2006;52:123-138.
31. Morvan A. De la choree fibrillaire. Gazette hebdomadaire de médecine et de chirurgie. 1890;27:173-176.
32. Liguori R, Vincent A, Clover L, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain. 2001;124:2417-2426.
33. Lee EK, Maselli RA, Ellis WG, Agius MA. Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry. 1998;65:857-862.
34. Barber PA, Anderson NE, Vincent A. Morvan's syndrome associated with voltage-gated K+ channel antibodies. Neurology. 2000;54:771-772.
35. Josephs KA SM, Vernino S, Fealey RD, Auger RG, Nippoldt TB. Physiological studies of Morvan's syndrome. Ann Neurol. 2001;50:S34.
36. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve. 2002;26:702-707.
37. Madrid A, Gil-Peralta A, Gil-Neciga E, Gonzalez J, Jarrin S. Morvan's fibrillary chorea: remission after plasmapheresis. J Neurol. 1996;243: 350-353.
38. Josephs KA, Silber MH, Fealey RD, Nippoldt TB, Auger RG, Vernino S. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol. 2004;21:440-445.
39. Caselli RJ, Boeve BF, Scheithauer BW, O'Duffy JD, Hunder GG. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology. 1999;53:1579-1581.
40. Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE. Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers-report of 5 cases. Neurology. 1991;41:228-233.
41. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol. 2003;60:164-171.
42. Brain L, Jellinek EH, Ball K. Hashimoto's disease and encephalopathy. Lancet. 1966;2:512-514.
43. Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgartner R, Hess C. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol. 1996;243:585-593.
44. Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006;63: 197-202.
45. Watemberg N, Greenstein D, Levine A. Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective. J Child Neurol. 2006;21:1-5.
46. Bohnen NI, Parnell KJ, Harper CM. Reversible MRI findings in a patient with Hashimoto's encephalopathy. Neurology. 1997;49:246-247.
47. Creutzfeldt CJ, Haberl RL. Hashimoto encephalopathy: a do-not-miss in the differential diagnosis of dementia. J Neurol. 2005;252:1285-1287.
48. Hussain NS, Rumbaugh J, Kerr D, Nath A, Hillis AE. Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy. Neurology. 2005;64:165-166.